Functional Food Used for Regulating Inflammation and Metabolism in Chronic Diseases

A special issue of Foods (ISSN 2304-8158). This special issue belongs to the section "Nutraceuticals, Functional Foods, and Novel Foods".

Deadline for manuscript submissions: 26 July 2024 | Viewed by 698

Special Issue Editors


E-Mail Website
Guest Editor
Centre for Public Health and Wellbeing, School of Health and Social Wellbeing, College of Health, University of the West of England, Bristol BS16 1QY, UK
Interests: functional food; nutrition; food science; nutritional status; biomarkers’ nutritional status
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Food Science and Technology Center, National University of Singapore Suzhou Research Institute, Suzhou 215123, China
Interests: functional food; nutrition; food science
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We invite your valuable contributions to a Special Issue focusing on Functional Foods in Regulating Inflammation and Metabolism for Chronic Disease Management. This endeavor aims to explore innovative approaches and insights into the dynamic relationship between functional foods and the intricate landscape of chronic diseases.

Contemporary research underscores the critical role of functional foods in modulating inflammation and metabolism, which are pivotal factors in chronic disease management. We encourage contributions that delve into the multifaceted aspects of this relationship, encompassing early-life exposures and their potential lasting health implications.

This Special Issue seeks original research and comprehensive reviews that illuminate the impact of functional foods on health outcomes, with a specific focus on mechanisms such as inflammation regulation, metabolic pathways, and their collective influence on chronic diseases. We welcome contributions that elucidate the nuanced connections between functional foods and health, spanning diverse perspectives from molecular and cellular levels to broader clinical implications.

We extend a cordial invitation for you to share your expertise and contribute to this Special Issue, fostering a collective understanding of how functional foods can play a pivotal role in regulating inflammation and metabolism for chronic disease management.

Dr. Zheng Feei Ma
Prof. Dr. Caili Fu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Foods is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • functional foods
  • inflammation
  • chronic diseases
  • metabolism
  • non-communicable diseases

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 3294 KiB  
Article
Anti-Inflammatory Effects of Artemisia argyi H. Fermented by Lactobacillus plantarum in the LPS-Induced RAW 264.7 Cells and DSS-Induced Colitis Model
by Ji Yun Lee, Ji-Hyun Kim, Ji Myung Choi, Byeong Wook Noh, Hyun Young Kim and Eun Ju Cho
Foods 2024, 13(7), 998; https://doi.org/10.3390/foods13070998 - 25 Mar 2024
Viewed by 557
Abstract
Ulcerative colitis is a chronic inflammatory disease caused by abnormal immune responses in the intestinal mucosa and gut microorganisms. Unlike other mugworts, Artemisia argyi H. (A. argyi H.) enhances antioxidant, anti-inflammatory, and anticancer effects, but the improvement effects against gut inflammation have [...] Read more.
Ulcerative colitis is a chronic inflammatory disease caused by abnormal immune responses in the intestinal mucosa and gut microorganisms. Unlike other mugworts, Artemisia argyi H. (A. argyi H.) enhances antioxidant, anti-inflammatory, and anticancer effects, but the improvement effects against gut inflammation have not yet been reported. Therefore, this study aimed to confirm the alleviation of the inflammatory state in the gut by A. argyi H. fermented with Lactobacillus plantarum (FAA), using lipopolysaccharide (LPS)-induced RAW 264.7 cells and dextran sulfate sodium (DSS)-induced colitis models. In vitro, FAA (10, 50, 100, and 200 μg/mL) was pretreated into RAW 264.7 cells, followed with LPS (100 ng/mL), which induced the cell damage. Meanwhile, in vivo, FAA (100, 200 mg/kg/day) was orally administered into 6-week-old C57BL/6N mice for 3 weeks. During the last week of FAA administration, 2.5% DSS was used to induce colitis. The results showed that FAA reduced the production of nitric oxide (p < 0.0001), tumor necrosis factor (TNF)-α, interleukin (IL)-6 (p < 0.0001), and IL-1β (p < 0.0001) in the LPS-induced RAW 264.7 cells. Moreover, in the DSS-induced colitis model, FAA alleviated clinical symptoms (p < 0.001), inhibited the inflammatory state by reducing the production of TNF-α (p < 0.0001) and interferon-γ in intestinal immune cells (p < 0.0001), and strengthened the intestinal barrier by increasing the number of goblet cells (p < 0.0001). Furthermore, the anti-inflammatory effects were confirmed by the alleviation of histological damage (p < 0.001) and down-regulation of the expression of inflammatory proteins (TLR4, p < 0.0001; MyD88, p < 0.0001; Cox-2, p < 0.0001). These results suggest the potential of FAA as a dietary ingredient for preventing inflammation in the gut. Full article
Show Figures

Graphical abstract

Back to TopTop